Search results
Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Stock Is Rallying But Financials Look Ambiguous: Will...
Simply Wall St. via Yahoo Finance· 2 years agoSupernus Pharmaceuticals (NASDAQ:SUPN) has had a great run on the share market with its stock up by...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain:...
Simply Wall St. via Yahoo Finance· 5 months agoMost readers would already know that Supernus Pharmaceuticals' (NASDAQ:SUPN) stock increased by 9.4%...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript November 8, 2022...
Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023
GuruFocus.com via Yahoo Finance· 4 months agoNet Sales Growth: Qelbree's net sales surged by 129% to $140.2 million in 2023, while GOCOVRI...
Insider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ...
GuruFocus.com via Yahoo Finance· 7 months agoSupernus Pharmaceuticals Inc (NASDAQ:SUPN), a biopharmaceutical company focused on developing and...
Supernus Pharmaceuticals (SUPN): A Hidden Gem in the Market? A Comprehensive Analysis of Its ...
GuruFocus.com via Yahoo Finance· 9 months agoSupernus Pharmaceuticals Inc (NASDAQ:SUPN) has recently seen a daily gain of 2.28%, despite a...
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's...
Benzinga via Yahoo Finance· 3 months agoOn Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an...
Q4 2023 Supernus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Jack Khattar; President, Chief Executive Officer, Secretary, Director; Supernus Pharmaceuticals Inc Timothy Dec; Chief Financial Officer, Senior Vice President; Supernus Pharmaceuticals ...
Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 8.7% CAGR over the last three...
Simply Wall St. via Yahoo Finance· 7 months agoIt hasn't been the best quarter for Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) shareholders, since...
Supernus Pharmaceuticals (NASDAQ:SUPN) investors are up 3.6% in the past week, but earnings have...
Simply Wall St. via Yahoo Finance· 1 year agoBy buying an index fund, you can roughly match the market return with ease. But if you buy good...